KALA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KALA BIO Inc is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows weak financial performance, insider selling, no positive trading signals, and no significant positive catalysts. The technical indicators and stock trend suggest bearish sentiment and limited short-term upside potential.
The MACD histogram is slightly positive but contracting, indicating weak momentum. RSI is neutral at 30.786, showing no clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its support level at 0.233, with resistance levels far above at 0.447 and 0.512. Overall, the technical outlook is bearish.
NULL identified. No recent news or significant positive developments.
Insider selling has increased by 177.30% over the last month. Financial performance is poor with declining net income (-15.49% YoY) and EPS (-44.56% YoY). The stock trend indicates a high probability of short-term losses (-2.64% in the next day).
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$7,564,000 (-15.49% YoY), and EPS declined to -1.07 (-44.56% YoY). Gross margin remains at 0 with no improvement.
No direct analyst ratings or price targets for KALA BIO Inc. However, analysts are optimistic about small-to-mid cap biotech outperformance in 2026, which may provide a long-term sector tailwind.
